* BioRestorative Therapies Inc BRTX.OQ reported a
quarterly
adjusted loss of 77 cents per share for the quarter ended in
June. The mean expectation of two analysts for the quarter was
for a loss of $1.19 per share.
* Revenue fell 8.6% to $65.00 thousand from a year ago;
analysts
expected $15.00 thousand.
* BioRestorative Therapies Inc's reported EPS for the
quarter was
a loss of 77 cents.
* The mean earnings estimate of analysts had risen by
about 23.2%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
* BioRestorative Therapies Inc shares had fallen by 37.4%
this
quarter and gained 0.4% so far this year.
* The company reported a quarterly loss of $2.98 million.
* Wall Street's median 12-month price target for
BioRestorative
Therapies Inc is $12.50
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 15 at 09:06 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -1.19 -0.77 Beat
Mar. 31 2023 -1.26 -1.53 Missed
Dec. 31 2022 -1.43 -1.19 Beat
Sep. 30 2022 -1.45 -1.28 Beat